GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FORECAST 2019-2027

Table of Content

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. DIAGNOSTIC IS THE MAJORLY USED APPLICATION
3.2.2. SOFTWARE SEGMENT IS ANTICIPATED TO GROW AT A SIGNIFICANT RATE
3.2.3. CANCER INSTITUTES HOLD THE LARGEST MARKET SHARE IN TERMS OF END-USER

4. MARKET DYNAMICS
4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVERS
4.2.1. INCREASE IN PERVASIVENESS OF CANCER
4.2.2. RISING GOVERNMENT AND NON GOVERNMENT INITIATIVES
4.2.3. ADVANCEMENT IN TECHNOLOGY
4.3. MARKET RESTRAINTS
4.3.1. CHALLENGES FACED IN THE USAGE OF EXOSOME
4.3.2. STRINGENT REGULATION
4.4. MARKET OPPORTUNITIES
4.4.1. LUCRATIVE GROWTH OPPORTUNITIES IN THE EMERGING ECONOMIES
4.4.2. INCREASE IN ADOPTION OF INNOVATIVE AND ADVANCED EXOSOME DIAGNOSTIC AND THERAPEUTIC PROCEDURES
4.5. MARKET CHALLENGES
4.5.1. LOW AWARENESS IN THE DEVELOPING COUNTRIES

5. MARKET BY APPLICATION
5.1. DIAGNOSTIC
5.2. THERAPEUTIC

6. MARKET BY PRODUCT
6.1. INSTRUMENT
6.2. REAGENT
6.3. SOFTWARE

7. MARKET BY END-USER
7.1. CANCER INSTITUTE
7.2. HOSPITAL
7.3. DIAGNOSTIC CENTER
7.4. OTHER END-USER

8. KEY ANALYTICS
8.1. PORTER’S FIVE FORCES MODEL
8.1.1. THREAT OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE
8.1.3. BARGAINING POWER OF BUYERS
8.1.4. BARGAINING POWER OF SUPPLIERS
8.1.5. THREAT OF COMPETITIVE RIVALRY
8.2. EXOSOME ETYMOLOGY
8.3. PATENT ANALYSIS
8.4. COMPONENTS OF EXOSOME
8.5. OPPORTUNITY MATRIX

9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. THE UNITED STATES
9.1.2. CANADA
9.2. EUROPE
9.2.1. GERMANY
9.2.2. FRANCE
9.2.3. THE UNITED KINGDOM
9.2.4. ITALY
9.2.5. SPAIN
9.2.6. REST OF EUROPE
9.3. ASIA PACIFIC
9.3.1. JAPAN
9.3.2. CHINA
9.3.3. INDIA
9.3.4. AUSTRALIA
9.3.5. SOUTH KOREA
9.3.6. REST OF ASIA PACIFIC
9.4. REST OF WORLD
9.4.1. LATIN AMERICA
9.4.2. MIDDLE EAST AND AFRICA

10. COMPETITIVE LANDSCAPE
10.1. COMPANY PROFILES
10.1.1. AETHLON MEDICAL, INC.
10.1.2. BIOCAT GMBH
10.1.3. CAPRICOR THERAPEUTICS, INC.
10.1.4. CODIAK BIOSCIENCES
10.1.5. EVOX THERAPEUTICS LTD.
10.1.6. EXOSOME DIAGNOSTICS INC.
10.1.7. HANSABIOMED LIFE SCIENCES LTD. (ACQUIRED BY LONZA)
10.1.8. HITACHI CHEMICAL DIAGNOSTICS, INC.
10.1.9. MALVERN INSTRUMENTS LTD.
10.1.10. MBL INTERNATIONAL CORPORATION
10.1.11. NANOSOMIX INC.
10.1.12. SISTEMIC LTD.
10.1.13. SYSTEM BIOSCIENCES (SBI)
10.1.14. THERMO FISHER SCIENTIFIC INC.
10.1.15. QIAGEN N.V.

TABLES LIST
TABLE 1 NOMENCLATURE OF EXOSOME PARTICLES
TABLE 2 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 3 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 4 GLOBAL DIAGNOSTIC MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 5 GLOBAL THERAPEUTIC MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 6 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY PRODUCT 2019-2027 ($ MILLION)
TABLE 7 GLOBAL INSTRUMENT MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 8 COMMERCIAL KITS AND REAGENTS EXAMPLES FOR THE ISOLATION OF EXOSOME
TABLE 9 GLOBAL REAGENT MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 10 GLOBAL SOFTWARE MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 11 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 12 GLOBAL CANCER INSTITUTE MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 13 GLOBAL HOSPITAL MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 14 EXOSOME ASSOCIATED PROTEIN IN CLINICAL DIAGNOSTICS USAGE
TABLE 15 GLOBAL DIAGNOSTIC CENTER MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 16 GLOBAL OTHER END-USER MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 17 TYPE OF PROTEINS FOUND IN EXOSOMES
TABLE 18 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 19 NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 20 EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 21 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 22 ESTIMATED MOST COMMON CANCERS DIAGNOSED IN AUSTRALIA 2017
TABLE 23 REST OF WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY REGION 2019-2027 ($ MILLION)


FIGURES LIST
FIGURE 1 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 2 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 3 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY DIAGNOSTIC 2019-2027 ($ MILLION)
FIGURE 4 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY THERAPEUTIC 2019-2027 ($ MILLION)
FIGURE 5 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY PRODUCT 2018 & 2027 (%)
FIGURE 6 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY INSTRUMENT 2019-2027 ($ MILLION)
FIGURE 7 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY REAGENT 2019-2027 ($ MILLION)
FIGURE 8 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY SOFTWARE 2019-2027 ($ MILLION)
FIGURE 9 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY END-USER 2018 & 2027 (%)
FIGURE 10 NUMBER OF PEOPLE WITH CANCER GLOBALLY 2005-2016 (MILLIONS)
FIGURE 11 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY CANCER INSTITUTE 2019-2027 ($ MILLION)
FIGURE 12 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY HOSPITAL 2019-2027 ($ MILLION)
FIGURE 13 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY DIAGNOSTIC CENTER 2019-2027 ($ MILLION)
FIGURE 14 INCIDENCE OF PATIENTS WITH CHRONIC DISEASES GLOBALLY 2005-2030 (MILLIONS)
FIGURE 15 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY OTHER END-USER 2019-2027 ($ MILLION)
FIGURE 16 PORTER’S FIVE FORCE MODEL
FIGURE 17 NUMBER OF PAPERS PUBLISHED ON EXOSOME 2003-2017
FIGURE 18 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 19 THE UNITED STATES EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 20 CANADA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 21 GERMANY EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 22 FRANCE EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 23 THE UNITED KINGDOM EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 24 ITALY EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 25 SPAIN EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 26 REST OF EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 27 JAPAN EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 28 CHINA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 29 INDIA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 30 AUSTRALIA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 31 SOUTH KOREA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 32 REST OF ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 33 LATIN AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 34 MIDDLE EAST AND AFRICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

List of Figures

FIGURES LIST
FIGURE 1 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 2 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 3 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY DIAGNOSTIC 2019-2027 ($ MILLION)
FIGURE 4 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY THERAPEUTIC 2019-2027 ($ MILLION)
FIGURE 5 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY PRODUCT 2018 & 2027 (%)
FIGURE 6 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY INSTRUMENT 2019-2027 ($ MILLION)
FIGURE 7 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY REAGENT 2019-2027 ($ MILLION)
FIGURE 8 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY SOFTWARE 2019-2027 ($ MILLION)
FIGURE 9 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY END-USER 2018 & 2027 (%)
FIGURE 10 NUMBER OF PEOPLE WITH CANCER GLOBALLY 2005-2016 (MILLIONS)
FIGURE 11 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY CANCER INSTITUTE 2019-2027 ($ MILLION)
FIGURE 12 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY HOSPITAL 2019-2027 ($ MILLION)
FIGURE 13 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY DIAGNOSTIC CENTER 2019-2027 ($ MILLION)
FIGURE 14 INCIDENCE OF PATIENTS WITH CHRONIC DISEASES GLOBALLY 2005-2030 (MILLIONS)
FIGURE 15 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY OTHER END-USER 2019-2027 ($ MILLION)
FIGURE 16 PORTER’S FIVE FORCE MODEL
FIGURE 17 NUMBER OF PAPERS PUBLISHED ON EXOSOME 2003-2017
FIGURE 18 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 19 THE UNITED STATES EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 20 CANADA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 21 GERMANY EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 22 FRANCE EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 23 THE UNITED KINGDOM EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 24 ITALY EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 25 SPAIN EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 26 REST OF EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 27 JAPAN EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 28 CHINA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 29 INDIA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 30 AUSTRALIA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 31 SOUTH KOREA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 32 REST OF ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 33 LATIN AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 34 MIDDLE EAST AND AFRICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

List of Tables

TABLES LIST
TABLE 1 NOMENCLATURE OF EXOSOME PARTICLES
TABLE 2 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 3 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 4 GLOBAL DIAGNOSTIC MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 5 GLOBAL THERAPEUTIC MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 6 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY PRODUCT 2019-2027 ($ MILLION)
TABLE 7 GLOBAL INSTRUMENT MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 8 COMMERCIAL KITS AND REAGENTS EXAMPLES FOR THE ISOLATION OF EXOSOME
TABLE 9 GLOBAL REAGENT MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 10 GLOBAL SOFTWARE MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 11 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 12 GLOBAL CANCER INSTITUTE MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 13 GLOBAL HOSPITAL MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 14 EXOSOME ASSOCIATED PROTEIN IN CLINICAL DIAGNOSTICS USAGE
TABLE 15 GLOBAL DIAGNOSTIC CENTER MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 16 GLOBAL OTHER END-USER MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 17 TYPE OF PROTEINS FOUND IN EXOSOMES
TABLE 18 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 19 NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 20 EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 21 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 22 ESTIMATED MOST COMMON CANCERS DIAGNOSED IN AUSTRALIA 2017
TABLE 23 REST OF WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY REGION 2019-2027 ($ MILLION)